Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats

Toxicology and Industrial Health

Volumn 24, Issue 8, 2008, Pages 519-524

  Yilmaz, Hr ^a   Uz, E ^a   Gokalp O ^a   Ozcelik N ^a   Cicek E ^a   Özer, Mk ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

adenosine deaminase; CAPE; erdosteine; isoniazid; nitric oxide; red blood cell; xanthine oxidase

Indexed keywords

ADENOSINE DEAMINASE; CAFFEIC ACID PHENETHYL ESTER; ERDOSTEINE; ISONIAZID; NITRIC OXIDE; PURINE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ERYTHROCYTE; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RAT; SPECTROPHOTOMETER;

ADENOSINE DEAMINASE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; ANTITUBERCULAR AGENTS; CAFFEIC ACIDS; DISEASE MODELS, ANIMAL; DRINKING; DRUG THERAPY, COMBINATION; ERYTHROCYTES; INJECTIONS, INTRAPERITONEAL; ISONIAZID; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PURINES; RATS; RATS, WISTAR; THIOGLYCOLATES; THIOPHENES; XANTHINE OXIDASE;

RATTUS;

EID: 57449116812     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233708098128     Document Type: Article

References (41)

1. Amacher DE, Schomaker SJ (1998) Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes. Toxicol Lett 94: 115–125.
2. Andrzheiuk NI, Smirnova NA, Narovlianskaia SE, Novoselova VP, Kruglova EG (1990) The pro-fibrotic and pro-oxidant action of isoniazid. Probl Tuberk 8: 7–11.
3. Attri S, Rana SV, Vaiphei K, Sodhi CP, Katyal R, Goel RC (2000) Isoniazid- and rifampicin-induced oxidative hepatic injury–protection by N-acetylcysteine. Hum Exp Toxicol 19: 517–522.
4. Balli F, Bergamini B, Calistru P, Ciofu EP, Domenici R, Doros G (2007) Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children. Int J Clin Pharmacol Ther 45: 16–22.
5. Banerjee T, Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol 124: 391–402.
6. Bor-Kucukatay M, Yalcin O, Gokalp O, Kipmen-Korgun D, Yesilkaya A, Baykal A (2000) Red blood cell rheological alterations in hypertension induced by chronic inhibition of nitric oxide synthesis in rats. Clin Hemorheol Microcirc 22: 267–275.
7. Braga PC, Dal Sasso MD, Zuccotti T (2000) Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneimittelforschung 50: 739–746.
8. Chen YJ, Shiao MS, Wang SY (2001) The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs 12: 143–149.
9. Cicek E, Sutcu R, Gokalp O, Yilmaz HR, Ozer MK, Uz E (2005) The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine. Mol Cell Biochem 277: 131–135.
10. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and ürine by a kinetic cadmium-reduction method. Clin Chem 36: 1440–1443.
11. Dacie JV, Lewis SM (1984) Practical Haematology. New York: Churchill Livingstone, pp. 32.
12. Dechant KL, Noble S (1996) Erdosteine. Drugs 52: 875–881.
13. Erdogan H, Fadillioglu E, Yagmurca M, Ucar M, Irmak MK (2006) Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 34: 41–46.
14. Fadillioglu E, Yilmaz HR, Erdogan H, Sogut S (2003) The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine. Toxicology 191: 153–158.
15. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 48: 595–608.
16. Gazzani G, Fregnan GB, Vandoni G (1989) In vitro protection by erdosteine against oxidative inactivation of alpha-1-antitrypsin by cigarette smoke. Respiration 55: 113–118.
17. Gebhart E, Kysela D, Matthee H, Nikol M (1985) Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives, and control individuals. Hum Genet 69: 309–315.
18. Giusti G (1974) Adenosine deaminase. In: MV Bergmeyer (ed), Methods of Enzymatic Analysis, second ed. New York: Academic Press, pp. 1092–1098.
19. Gokalp O, Uz E, Cicek E, Yilmaz HR, Ozer MK, Altunbasak A (2006) Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells. Mol Cell Biochem 290: 55–59.
20. Ince H, Kandemir E, Bagci C, Gulec M, Akyol O (2006) The effect of caffeic acid phenethyl ester on short-term acute myocardial ischemia. Med Sci Monit 12: BR187–BR193.
21. Jones HB, Cavanagh JB (1981) Comparison between the early changes in isoniazid intoxication and the chromatolytic response to nerve ligation in spinal ganglion cells of the rat. Neuropathol Appl Neurobiol 7: 489–501.
22. Kalcioglu MT, Kizilay A, Yilmaz HR, Uz E, Gulec M, Ozturan O (2004) Adenosine deaminase, xanthine oxidase, superoxide dismutase, glutathione peroxidase activities and malondialdehyde levels in the sera of patients with head and neck carcinoma. Kulak Burun Boğaz İhtis Derg 12: 16–22.
23. Koltuksuz U, Mutuş HM, Kutlu R, Ozyurt H, Cetin S, Karaman A (2001) Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats. J Pediatr Surg 36: 1504–1509.
24. Lewis CR, Manoharan A (1987) Pure red cell hypoplasia secondary to isoniazid. Postgrad Med J 63: 309–310.
25. Michaluart P, Masferrer JL, Carothers AM, Subbaramaiah K, Zweifel BS, Koboldt C (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res 59: 2347–2352.
26. National Institutes of Health Guide for the Care and Use of Laboratory Animals, DHEW Publication No. (NIH) 85–23, Revised (1985) Office of Science and Health Reports. Bethesda, USA: DRR/NIH.
27. Park JH, Lee JK, Kim HS, Chung ST, Eom JH, Kim KA (2004) Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. Int Immunopharmacol 4: 429–436.
28. Prajda N, Weber G (1975) Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett 59: 245–249.
29. Rubbo H, O'Donnell V (2005) Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. Toxicology 208: 305–317.
30. Sahin M, Cam H, Olgar S, Tunc SE, Arslan C, Uz E (2006) Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver. Mol Cell Biochem 291: 155–160.
31. Shah BR, Santucci K, Sinert R, Steiner P (1995) Acute isoniazid neurotoxicity in an urban hospital. Pediatrics 95: 700–704.
32. Sodhi CP, Rana SV, Mehta SK, Vaiphei K, Attri S, Thakur S (1996) Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition. J Biochem Toxicol 11: 139–146.
33. Sogut S, Kotuk M, Yilmaz HR, Ulu R, Ozyurt H, Yildirim Z (2004) In vivo evidence suggesting a role for purine-catabolizing enzymes in the pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity. Cell Biochem Funct 22: 157–162.
34. Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 329: 21–24.
35. Thomas BH, Whitehouse LW, Zeitz W (1984) Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit. Fundam Appl Toxicol 4: 646–653.
36. Uz E, Oktem F, Yilmaz HR, Uzar E, Ozgüner F (2005) The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 277: 165–170.
37. Uzar E, Sahin O, Koyuncuoglu HR, Uz E, Bas O, Kilbas S (2006) The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: protective effect of caffeic acid phenethyl ester. Toxicology 218: 125–133.
38. Yilmaz HR, Iraz M, Sogut S, Ozyurt H, Yildirim Z, Akyol O (2004a) The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res 50: 287–290.
39. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N (2004b) Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18: 234–238.
40. Yilmaz HR, Sogut S, Ozyurt B, Ozugurlu F, Sahin S, Isik B (2005) The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester. Toxicol Ind Health 21: 67–73.
41. Yoshimoto S, Takeuchi M, Tada A (1992) Secondary sideroblastic anemia caused by long term administration of anti-tuberculous agents including isoniazid. Rinshō Ketsueki 33: 986–990.